We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

PROMEGA

Promega has a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression,... read more Featured Products: More products

Download Mobile App




Test Combination Detects Latent Leishmaniasis Infection

By LabMedica International staff writers
Posted on 01 Sep 2022

After infection with Leishmania infantum cutaneous or visceral leishmaniasis can develop, but in most cases the host becomes an asymptomatic carrier of the parasite. More...

This key population of individuals with latent leishmaniasis can undergo reactivation of the infection with severe outcome in case of immunosuppression and can contribute to disease transmission.

The public health impact of leishmaniasis is currently underestimated in Europe, despite Leishmania infection is endemic in the Mediterranean countries and outbreaks of human leishmaniasis have been reported in the last decades, including northeastern Italy. One of the causes contributing to this neglect is that the available diagnostic tests exhibit scarce sensitivity in identification of latent leishmaniasis.

Diagnostic Microbiologists at the University of Bologna (Bologna, Italy) and their colleagues enrolled a cohort of 145 adult volunteers residing in a selected Bologna province, with the aim to perform a screening for asymptomatic Leishmania infection. For each individual, 10 mL of peripheral blood were collected and divided into three test tubes; one tube with ethylenediamine tetraacetic acid (EDTA) as anticoagulant, one tube with heparin as anticoagulant, and one tube without anticoagulant. The team defined as asymptomatic Leishmania infection each case that tested positive to at least one of the screening tests: Real-Time PCR, Western Blot (WB), and/or Whole Blood stimulation Assay (WBA).

The detection of specific Leishmania IgG in serum of volunteers was assessed employing the Leishmania WESTERN BLOT IgG kit (LDBio Diagnostics, Lyon, France). WBA was assessed to study the cytokine release by leukocytes upon stimulation with Leishmania antigens. The quantification of IL-2 was performed using Cytometric Bead Array Human Soluble Protein Flex Set (Becton Dickinson, Franklin Lakes, NJ, USA) and the method was performed using that company’s BD FACSCanto. Leishmanial DNA was extracted from 200 μL of EDTA peripheral blood by a semi-automatic DNA extraction system, using the Maxwell 16 LEV Blood DNA kit on the Maxwell 16 instrument (Promega, Madison, WI, USA;) for the detection of parasitic DNA in the blood.

The investigators reported that 23/145 volunteers were positive, indicating a prevalence of 15.9%; 15/145 subjects tested positive to WB (10.3%). In detail, four subjects showed positivity to the p14 band (26.5%), seven to the p16 band (47.0%), and four to both p14 and p16 bands (26.5%). Among the 145 volunteers included in the study, six individuals carried leishmanial DNA in the peripheral blood (4.1%); the parasitaemia was low, with a median parasite load of 8.24 × 10−1 /mL of blood. The WBA was used to evaluate the specific cell-mediated response of the volunteers after blood stimulation with Leishmania-specific antigens. Of the 145 subjects, 12 tested positive (8.3%); these individuals exhibited an IL-2 value above the cut-off of positivity with a median IL-2 concentration of 213 pg/mL.

The authors concluded that combining different tests substantially increased the yield of positivity in detecting latent Leishmania infection. The test combination that they employed in this study appears to be effective to accurately identify latent leishmaniasis in an endemic area. The study was published on August 15, 2022 in the journal PLoS Neglected Tropica Diseases.

 

 


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
PSA Assay
CanAg PSA EIA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.